Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growthin Vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growthin Vivo
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 41, Pages 29562-29572
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-08-27
DOI
10.1074/jbc.m113.498436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Imaging Ligand-Dependent Activation of CXCR7
- (2015) Kathryn E. Luker et al. NEOPLASIA
- Expression and Functional Heterogeneity of Chemokine Receptors CXCR4 and CXCR7 in Primary Patient-Derived Glioblastoma Cells
- (2013) Che Liu et al. PLoS One
- Role of chemokine receptor CXCR7 in bladder cancer progression
- (2012) Mingang Hao et al. BIOCHEMICAL PHARMACOLOGY
- CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients
- (2012) M Schrevel et al. BRITISH JOURNAL OF CANCER
- Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists
- (2012) Maikel Wijtmans et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chemokine and Chemokine Receptor Expression in Kidney Tumors: Molecular Profiling of Histological Subtypes and Association With Metastasis
- (2012) Jeffrey C. Gahan et al. JOURNAL OF UROLOGY
- Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
- (2012) M. J. W. D. Vosjan et al. MOLECULAR CANCER THERAPEUTICS
- Ubiquitination of CXCR7 Controls Receptor Trafficking
- (2012) Meritxell Canals et al. PLoS One
- Pharmacological modulation of chemokine receptor function
- (2011) DJ Scholten et al. BRITISH JOURNAL OF PHARMACOLOGY
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- Immuno-imaging using nanobodies
- (2011) Ilse Vaneycken et al. CURRENT OPINION IN BIOTECHNOLOGY
- Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
- (2011) Ilse Vaneycken et al. FASEB JOURNAL
- Expressions of CXCR7/ligands may be involved in oral carcinogenesis
- (2011) Juan Xia et al. JOURNAL OF MOLECULAR HISTOLOGY
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
- (2011) Brian A Zabel et al. Molecular Cancer
- Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor
- (2011) Mahdi Behdani et al. MOLECULAR IMMUNOLOGY
- CXCR7 Protein Expression in Human Adult Brain and Differentiated Neurons
- (2011) Saori Shimizu et al. PLoS One
- Alteration of CXCR7 Expression Mediated by TLR4 Promotes Tumor Cell Proliferation and Migration in Human Colorectal Carcinoma
- (2011) Huanbai Xu et al. PLoS One
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- Optical imaging predicts tumor response to anti-EGFR therapy
- (2010) Emily E. Helman et al. CANCER BIOLOGY & THERAPY
- The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
- (2010) K. Hattermann et al. CANCER RESEARCH
- Chemokine receptor CXCR7 regulates the invasion,angiogenesis and tumor growth of human hepatocellular carcinoma cells
- (2010) Ke Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands
- (2010) K E Luker et al. ONCOGENE
- CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
- (2010) Ulrike Naumann et al. PLoS One
- CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
- (2010) S. Jahnichen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands
- (2009) B. A. Zabel et al. JOURNAL OF IMMUNOLOGY
- -arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7
- (2009) S. Rajagopal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptomic dissection of tongue squamous cell carcinoma
- (2008) Hui Ye et al. BMC GENOMICS
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression
- (2008) Lieven Huang et al. MOLECULAR IMAGING AND BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started